Fig. 2
From: The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis

First observed evidence of comorbidities during the 5 years prior to diagnosis
From: The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis
First observed evidence of comorbidities during the 5 years prior to diagnosis